The Growth Of National Steel Car Under The Leadership Of Gregory Aziz

Gregory J. Aziz has always had a strong skillset for business development. For instance, during his first role in business development at his family’s business, Greg Aziz managed to grow the company on a global scale. The company, Affiliated Foods, started as a company that did business specifically in a regional capacity in Canada. After working there several years, Greg James Aziz managed to transition the company into a global entity. Affiliated Foods was doing business in nearly every major continent and was working with major distributors in South America, Europe, Africa as well as all of Canada and the United States.

 

He put that skill to work at National Steel Car. After being hired, he soon became the company’s main leader. Today, he holds the titles of Chief Executive Officer, Chairman of the Board and the prestigious role of the company’s President.

 

After he joined the company Gregory James Aziz immediately made major moves to expand the company’s production, as well as its employee base. During his first few years at National Steel Car, Greg Aziz grew the company’s employee base from just around 800 people to over 2,000 people.

 

This growth was massive for the company and for the entire community of Hamilton, Ontario. The influx of jobs drew people to relocate to the town and it also drew in the opening of new businesses that created even more jobs. The 1influx of jobs had a ripple effect that made Hamilton one of the most booming places to move to in the Ontario area. Go To This Page for more information.

 

In addition to the influx of new jobs, Gregory James Aziz also rapidly increased the production of steel freight cars that National Steel Car was able to product annually. The company went from producing around 3,500 steel freight railway cars annually to well over 12,000 railway cars each year. That volume of growth put National Steel Car on the map as far as being a main producer of steel railway cars.

 

The company went from being a Canadian entity to becoming a global leader in the production of railway cars that transport freight. The company has achieved major accomplishments throughout North America under the leadership of Greg Aziz. Year over year, National Steel Car has seen expansion both in the volume of employees as well as the volume of steel freight railway cars that it produces on an annual basis. In fact, National Steel Car is now a world-wide leader in the production of freight cars for railroad transport.

 

More on: https://www.steelcar.com/

Scott Rocklage Impact In The World Of Science

The disease of muscular dystrophy is beginning to lose the battle against modern medical research thanks in a big part to Scott Rocklage, PhD, who is the managing partner of 5AM Ventures. A leading venture capital company for the healthcare industry’s research, technology and drug development efforts.

 

Scott Rocklage became a venture partner with 5AM Ventures in 2003, in 2004 he was appointed the managing partner and has maintained that position with immense success ever since. His latest endeavors include teaming up with other venture capitalist in the healthcare industry to tackle Myotonic dystrophy I (DM1) which is the primary cause of adult muscular dystrophy. All of the venture capital companies combined have recently added $55.3 million dollars to the fight.

 

The lab soldiers in the fight are being lead by Expansion Therapeutics, a drug research and development company who’s recent findings have uncovered that symptoms of the chronic disease appear when toxic levels of RNA are reached. RNA molecular transfer from a patient’s DNA is converted to proteins and reaches a toxic level then Myotonic dystrophy I sets in. Causing major nervous system and other systems in the body to break down and become defective.

 

Lead by research from the lab of Matthew D Disney, PhD. Expansion Therapeutics is developing small molecule medications to fight the disease related RNA to arrest the growth of toxic levels. Learn more: http://www.rennovia.com/team/scott-m-rocklage/

 

Currently RNA triggered disease such as myotonic dystrophy at the time have no way of being treated but this is a huge step toward overcoming that challenge and the entire Expansion Therapeutics team is determined to give both hope and treatment to those patients who have neither right now. In addition to treating toxic RNA levels with small molecule medications the research team is at the same time working to develop medicines and treatments for patients that have direct medical needs as well.

 

The optimism and hope the researchers are expressing can be reinforced by the fact that they have Scott Rocklage in their corner for this fight. He has been responsible for getting approval for the innovative medications Teslascan, Omniscan and Cubicin from the FDA as well as being the inventor or co-inventor of 30 United States Patents. He began his education at Cal Berkeley with a major in Chemistry and then went on to receive his PhD. in the same major at M.I.T.

 

Rocklage can be found operating the 5AM Ventures main office in Boston these days.